Miller Global Investments, LLC
Source: SEC Form 13F · as of Mar 2026Miller Global Investments, LLC holds 21 biotech & pharma companies tracked by BioSniper, totaling $6.4M in value as of Mar 2026 (SEC Form 13F).
Companies held
21
Total value held
$6.4M
| Company | Shares | Value |
|---|---|---|
| BMYBRISTOL MYERS SQUIBB CO | 20,632 | $1.3M |
| PFEPFIZER INC | 35,582 | $999K |
| RPRXRoyalty Pharma plc | 10,870 | $521K |
| MRKMerck & Co., Inc. | 4,319 | $520K |
| BMRNBIOMARIN PHARMACEUTICAL INC | 8,696 | $491K |
| ELVElevance Health Inc. | 1,471 | $431K |
| GMEDGlobus Medical Inc. | 4,241 | $365K |
| CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC. | 2,049 | $353K |
| ICLRICON plc | 2,304 | $255K |
| JNJJOHNSON & JOHNSON | 950 | $232K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 819 | $222K |
| TEVATeva Pharmaceutical Industries Limited | 4,881 | $147K |
| LLYELI LILLY & Co | 144 | $132K |
| ABTABBOTT LABORATORIES | 1,044 | $107K |
| NVONovo Nordisk A/S | 2,831 | $104K |
| NAGENiagen Bioscience, Inc. | 18,800 | $83K |
| AMGNAMGEN INC | 185 | $65K |
| PMPhilip Morris International Inc | 250 | $41K |
| ABBVAbbVie Inc. | 145 | $32K |
| NEONeoGenomics Inc. | 457 | $3K |
| GMABGenmab A/S | 77 | $2K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.